02/17/2021
3:21 PM | Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2021
11:15 PM | Oramed Pharmaceuticals (Filer)
| Form EFFECT
| |
02/09/2021
2:52 PM | Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
| Form SC 13G/A
| |
02/08/2021
4:31 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
4:30 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
4:29 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2021
4:29 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2021
3:51 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2021
3:11 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
12/02/2020
7:43 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/01/2020
4:23 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2020
4:14 PM | Oramed Pharmaceuticals (Filer)
| Form 424B5
| |
11/24/2020
6:37 AM | Oramed Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
10/22/2020
3:05 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2020
3:05 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
3:13 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2020
3:33 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2020
3:39 PM | Oramed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/15/2020
8:16 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/07/2020
3:13 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/30/2020
3:09 PM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A
| |
06/16/2020
3:28 PM | Oramed Pharmaceuticals (Filer)
| Form PRE 14A
| |
04/09/2020
3:42 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/06/2020
3:46 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/02/2020
10:44 AM | Oramed Pharmaceuticals (Filer)
| Form 424B5
| |
02/28/2020
12:10 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2020
7:03 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
10:54 AM | Altium Capital Management LP (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/11/2020
10:46 AM | Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
| Form SC 13G
| |
02/10/2020
11:15 PM | Oramed Pharmaceuticals (Filer)
| Form EFFECT
| |
02/10/2020
4:28 PM | Oramed Pharmaceuticals (Filer)
| Form 424B5
| |
01/21/2020
1:40 PM | Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
01/14/2020
3:08 PM | Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:07 PM | Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:06 PM | Mayer Arie (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:06 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:05 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:04 PM | Oramed Pharmaceuticals (Issuer)
Xiaoming Gao (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2020
3:04 PM | Friedman Aviad (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2020
2:57 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/27/2019
3:26 PM | Oramed Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/12/2019
6:04 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2019
3:35 PM | Oramed Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/16/2019
5:08 PM | Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
5:07 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
5:07 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
5:06 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
5:04 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2019
5:02 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2019
4:17 PM | Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2019
3:49 PM | Oramed Pharmaceuticals (Filer)
| Form 424B5
| |
09/05/2019
3:41 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2019
4:27 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
12:29 PM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A
| |
07/29/2019
5:07 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2019
11:11 AM | Oramed Pharmaceuticals (Issuer)
Xiaoming Gao (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2019
12:31 PM | Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2019
6:02 PM | Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2019
4:26 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/01/2019
2:18 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2019
3:20 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2019
3:23 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2019
4:09 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2019
4:01 PM | Oramed Pharmaceuticals (Issuer)
Slager David Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2019
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2019
4:07 PM | Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2019
4:21 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/28/2019
3:56 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2019
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
3:17 PM | Altium Capital Management LP (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13G/A
| |
01/14/2019
4:20 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
01/07/2019
8:01 AM | Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/14/2018
7:04 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2018
4:16 PM | Oramed Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/20/2018
3:58 PM | Hasleton Mark Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2018
4:02 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2018
10:59 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2018
3:51 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2018
3:32 PM | Friedman Aviad (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2018
4:15 PM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A
| |
07/20/2018
4:25 PM | Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
| Form SC 13D/A
| |
07/20/2018
4:17 PM | KIDRON NADAV (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13D/A
| |
07/12/2018
4:18 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2018
4:11 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2018
3:57 PM | ARMISTICE CAPITAL, LLC (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13G
| |
07/05/2018
3:32 PM | Oramed Pharmaceuticals (Filer)
| Form 424B5
| |
07/05/2018
3:10 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2018
8:58 AM | Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
05/07/2018
3:51 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2018
9:55 AM | Oramed Pharmaceuticals (Filer)
| Form CT ORDER
| |
04/10/2018
4:41 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2018
4:14 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/20/2018
1:04 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2018
4:36 PM | Eisenberg Hilla (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2018
4:34 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2018
4:32 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2018
12:09 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/29/2017
4:23 PM | Oramed Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
